Hexagon Nutrition Reports Strong Revenue Growth Amidst Margin Concerns

Hexagon Nutrition's revenue from operations surged by 43.2% to Rs 104.3 crore in the first quarter of FY27, up from Rs 72.9 crore in Q1 FY26. The company also holds a current order book of Rs 100 crore, with most of it expected to be executed in the second quarter and partly in the third quarter.

Reader Takeaway: Strong revenue growth with a healthy order book, but margin compression due to rising costs.

What just happened

Hexagon Nutrition announced its Q1 FY27 financial results, showcasing a significant 43.2% year-on-year increase in revenue from operations, reaching Rs 104.3 crore. This growth was driven by a 55% rise in the Premix segment, a 28% increase in the Branded segment, and a 42% jump in the Therapeutic/ESG segment. The company also reported a 25.1% rise in Profit After Tax (PAT) to Rs 8.1 crore, and an EBITDA of Rs 11.8 crore, up 17.3%.

Why this matters

The robust revenue growth indicates strong market demand for Hexagon Nutrition's products. The substantial order book provides visibility for future earnings. However, the contraction in gross margin by over 3% due to increased raw material and freight costs, exacerbated by the West Asia crisis, poses a challenge to profitability.

The backstory

Hexagon Nutrition, a player in the nutraceutical industry, has been focusing on expanding its product offerings and market reach. The company's segment mix shows Premix contributing the largest share (~62%) of revenue, followed by Branded products (~28%) and Therapeutic/ESG (~10%). The blended capacity utilization stands at 47%.

What changes now

To combat margin compression, Hexagon Nutrition plans to implement MRP hikes of 10-15% for its branded products, with an expected impact from the second quarter onwards. The company is also planning capital expenditure of Rs 25-30 crore over the next 12-18 months for the redevelopment of its Nashik factory. Management projects a conservative revenue growth of 20-25% for the full fiscal year FY27.

Risks to watch

The primary risk is the execution of the planned MRP hikes and their impact on consumer demand. The company's profitability could be further affected if input costs and freight charges continue to rise. Additionally, the ESG segment's reliance on tenders can lead to quarterly fluctuations in order volumes.

Peer comparison

(No specific peer data available in the filing).

Context metrics (time-bound)

• Revenue from operations: Rs 104.3 crore (Q1 FY27) vs Rs 72.9 crore (Q1 FY26).
• Gross Profit: Rs 45.8 crore (Q1 FY27) vs Rs 34.1 crore (Q1 FY26).
• EBITDA: Rs 11.8 crore (Q1 FY27) vs Rs 10.1 crore (Q1 FY26).
• PAT: Rs 8.1 crore (Q1 FY27) vs Rs 6.5 crore (Q1 FY26).
• Order Book: Rs 100 crore (current).
• Capacity Utilization: 47% (blended).

What to track next

Investors will be closely watching the effectiveness of the MRP hikes in restoring margins, the actual revenue growth against the projected 20-25% for FY27, and the company's ability to manage rising input and logistics costs in the face of geopolitical challenges.